Evaluation of ER-α, ER-β1 and ER-β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers

被引：0
|
作者：
Huiming Zhang
Zhongtao Zhang
Lixue Xuan
Shan Zheng
Lei Guo
Qimin Zhan
Xiang Qu
Baoning Zhang
Yu Wang
Xiang Wang
Yongmei Song
机构：
[1] Capital Medical University,Department of General Surgery Beijing Friendship Hospital
[2] Chinese Academy of Medical Sciences,Department of Abdominal Surgery Cancer Institute & Hospital
[3] Chinese Academy of Medical Sciences,Department of Pathology Cancer Institute & Hospital
[4] Chinese Academy of Medical Sciences,State Key Laboratory of Molecular Oncology Cancer Institute & Hospital
来源：
Clinical and Translational Oncology | 2012年 / 14卷
关键词：
Luminal subtype; Breast cancer; ER-β1; ER-β2 (ER-βcx); Immunohistochemistry; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 231
页数：6
相关论文
共 50 条
  • [31] RISK OF ER+ AND ER- BREAST-CANCER - INTERACTION OF MISCARRIAGE HISTORY WITH ER POLYMORPHISM
    LEHRER, S
    HARLAP, J
    RABIN, J
    SCHACHTER, BS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (11) : S69 - S69
  • [32] Role of ER-α36 in breast cancer by typical xenoestrogens
    Liu, Jun
    Xu, Zhixiang
    Ma, Xiaodong
    Huang, Bin
    Pan, Xuejun
    [J]. TUMOR BIOLOGY, 2015, 36 (10) : 7355 - 7364
  • [33] Expression of estrogen receptor variants in ER plus basal-type breast cancers that respond to therapy like ER- breast cancers.
    Whitworth, Pat W.
    Baron, Paul
    Beitsch, Peter D.
    Yoder, Erin
    Treece, Tina
    Audeh, M. William
    Dinjens, Winand N. M.
    Bernards, Rene
    Groenendijk, Floris
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Progesterone (PR), Oestrogen (ER-α and ER-β) and Oxytocin (OTR) Gene Expression in the Oviduct and Uterus of Pregnant and Non-pregnant Bitches
    Derussi, A. A. P.
    de Souza, R. W. A.
    Volpato, R.
    Guaitolini, C. R. F.
    Ackermann, C. L.
    Taffarel, M. O.
    Cardoso, G. S.
    Dal-Pai-Silva, M.
    Lopes, M. D.
    [J]. REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 197 - 199
  • [35] Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α
    IP Nyamagana Butera
    S Hadiy
    G Leclercq
    [J]. Breast Cancer Research, 3 (Suppl 1)
  • [36] Differential expression of VEGF-A mRNA by 17β-estradiol in breast tumor cells lacking classical ER-α may be mediated through a variant form of ER-α
    Krishanu Sengupta
    Snigdha Banerjee
    Neela K. Saxena
    Nira Ben Jonathan
    Donald R. Campbell
    Sushanta K. Banerjee
    [J]. Molecular and Cellular Biochemistry, 2004, 262 : 215 - 224
  • [37] Differential expression of VEGF-A mRNA by 17β-estradiol in breast tumor cells lacking classical ER-α may be mediated through a variant form of ER-α
    Sengupta, K
    Banerjee, S
    Saxena, NK
    Ben Jonathan, N
    Campbell, DR
    Banerjee, SK
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 262 (1-2) : 215 - 224
  • [38] The chemo-preventive effect of ER-β agonist on DMBA induced breast cancers
    Choi, Young J.
    Cheong, Yehwang
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [39] Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma
    Elkhouly, E. A.
    Abdelraziq, E.
    Rageh, T.
    Serag, M.
    Abdou, A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 195 - 195
  • [40] Risk factors for early-onset ER- and ER plus breast cancer in African American women
    Bertrand, Kimberly A.
    Rosenberg, Lynn
    Palmer, Julie R.
    [J]. CANCER RESEARCH, 2016, 76
12345